Faeth Therapeutics, Inc. Finance Lease, Right-of-Use Asset, after Accumulated Amortization
Faeth Therapeutics, Inc. (FTH) had Finance Lease, Right-of-Use Asset, after Accumulated Amortization of $0 as of 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:FinanceLeaseRightOfUseAsset · last filed 2026-08-04
- 2026-06-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2026-03-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $0.00.
- 2025-12-31: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $1.00K.
- 2025-09-30: Finance Lease, Right-of-Use Asset, after Accumulated Amortization $6.00K.
| Period end | Finance Lease, Right-of-Use Asset, after Accumulated Amortization |
|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-04 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-15 |
| 2025-12-31 | $1.00K 10-Q · filed 2026-08-04 |
| 2025-09-30 | $6.00K 10-Q · filed 2025-11-14 |
| 2025-06-30 | $10.00K 10-Q · filed 2025-08-05 |
| 2025-03-31 | $15.00K 10-Q · filed 2025-05-06 |
| 2024-12-31 | $163.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $964.00K 10-Q · filed 2024-11-14 |
| 2024-06-30 | $1.16M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $1.35M 10-Q · filed 2024-05-09 |
| 2023-12-31 | $1.54M 10-K · filed 2025-03-28 |
| 2023-09-30 | $1.74M 10-Q · filed 2023-11-07 |
| 2023-06-30 | $1.94M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $2.13M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $2.32M 10-K · filed 2024-02-29 |
| 2022-09-30 | $2.40M 10-Q · filed 2022-11-08 |
| 2022-06-30 | $2.42M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.55M 10-Q · filed 2022-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |